Literature DB >> 19951906

Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons.

Alona Zilberberg1, Lital Lahav, Rina Rosin-Arbesfeld.   

Abstract

Adenomatous polyposis coli (APC) is a multifunctional tumour suppressor protein that negatively regulates the Wnt signalling pathway. The APC gene is ubiquitously expressed in tissues and organs, including the large intestine and central nervous system. The majority of patients with sporadic and hereditary colorectal cancer have mutations in the gene encoding APC. Approximately 30% of these mutations are single nucleotide changes that result in premature stop codons (nonsense mutations). A potential therapeutic approach for treatment of this subset of patients is the use of aminoglycosides and macrolides that induce nonsense mutation read-through and restore levels of full-length protein. We have used reporter plasmids and colorectal cancer cell lines to demonstrate that several aminoglycosides and tylosin, a member of the macrolide family, induced read-through of nonsense mutations in the APC gene. In xenograft experiments and in the Apc(Min/+) mouse model, these compounds ameliorated the tumorigenic clinical symptoms caused by nonsense mutations in the APC gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951906     DOI: 10.1136/gut.2008.169805

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

Review 1.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.

Authors:  William Hankey; Wendy L Frankel; Joanna Groden
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

2.  When Proteins Start to Make Sense: Fine-tuning Aminoglycosides for PTC Suppression Therapy.

Authors:  Moran Shalev; Timor Baasov
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

3.  Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing.

Authors:  Miguel Crespo; Eduardo Vilar; Su-Yi Tsai; Kyle Chang; Sadaf Amin; Tara Srinivasan; Tuo Zhang; Nina H Pipalia; Huanhuan Joyce Chen; Mavee Witherspoon; Miriam Gordillo; Jenny Zhaoying Xiang; Frederick R Maxfield; Steven Lipkin; Todd Evans; Shuibing Chen
Journal:  Nat Med       Date:  2017-06-19       Impact factor: 53.440

4.  Present and Future Prospect of Small Molecule & Related Targeted Therapy Against Human Cancer.

Authors:  Akshat Pathak; Sanskriti Tanwar; Vivek Kumar; Basu Dev Banarjee
Journal:  Vivechan Int J Res       Date:  2018

5.  A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.

Authors:  Michal Caspi; Anastasia Firsow; Raja Rajkumar; Nir Skalka; Itay Moshkovitz; Ariel Munitz; Metsada Pasmanik-Chor; Hagar Greif; Dalia Megido; Revital Kariv; Daniel W Rosenberg; Rina Rosin-Arbesfeld
Journal:  J Mol Med (Berl)       Date:  2015-12-01       Impact factor: 4.599

Review 6.  Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases.

Authors:  Liutao Du; Richard A Gatti
Journal:  J Immunol Methods       Date:  2010-12-13       Impact factor: 2.303

Review 7.  Therapeutics based on stop codon readthrough.

Authors:  Kim M Keeling; Xiaojiao Xue; Gwen Gunn; David M Bedwell
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-18       Impact factor: 8.929

8.  Regulation of gene expression by macrolide-induced ribosomal frameshifting.

Authors:  Pulkit Gupta; Krishna Kannan; Alexander S Mankin; Nora Vázquez-Laslop
Journal:  Mol Cell       Date:  2013-11-14       Impact factor: 17.970

9.  A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM gene.

Authors:  Liutao Du; Michael E Jung; Robert Damoiseaux; Gladys Completo; Francesca Fike; Jin-Mo Ku; Shareef Nahas; Cijing Piao; Hailiang Hu; Richard A Gatti
Journal:  Mol Ther       Date:  2013-06-18       Impact factor: 11.454

10.  Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA.

Authors:  Renata Bordeira-Carriço; Daniel Ferreira; Denisa D Mateus; Hugo Pinheiro; Ana Paula Pêgo; Manuel A S Santos; Carla Oliveira
Journal:  Eur J Hum Genet       Date:  2014-01-15       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.